Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1990-12-5
pubmed:abstractText
Ser130, Asp131 and Asn132 ('SDN') are highly conserved residues in class A beta-lactamases forming one wall of the active-site cavity. All three residues of the SDN loop in Streptomyces albus G beta-lactamase were modified by site-directed mutagenesis. The mutant proteins were expressed in Streptomyces lividans, purified from culture supernatants and their kinetic parameters were determined for several substrates. Ser130 was substituted by Asn, Ala and Gly. The first modification yielded an almost totally inactive protein, whereas the smaller-side-chain mutants (A and G) retained some activity, but were less stable than the wild-type enzyme. Ser130 might thus be involved in maintaining the structure of the active-site cavity. Mutations of Asp131 into Glu and Gly proved to be highly detrimental to enzyme stability, reflecting significant structural perturbations. Mutation of Asn132 into Ala resulted in a dramatically decreased enzymic activity (more than 100-fold) especially toward cephalosporin substrates, kcat. being the most affected parameter, which would indicate a role of Asn132 in transition-state stabilization rather than in ground-state binding. Comparison of the N132A and the previously described N132S mutant enzymes underline the importance of an H-bond-forming residue at position 132 for the catalytic process.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-1974463, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-2300174, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-2302162, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-2326252, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-2506109, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-2550326, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-2658779, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-2658780, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-2658781, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-2822004, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-3001650, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-3013728, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-3038122, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-3055170, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-3107125, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-3124817, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-3128280, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-3499147, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-3513181, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-3896783, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-590266, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-6109327, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-6299270, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-6313861, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-6425288, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-6631413, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-6773559, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-6983070, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-6994800, http://linkedlifedata.com/resource/pubmed/commentcorrection/2173561-7181854
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
271
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
399-406
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:2173561-Amino Acid Sequence, pubmed-meshheading:2173561-Asparagine, pubmed-meshheading:2173561-Aspartic Acid, pubmed-meshheading:2173561-Base Sequence, pubmed-meshheading:2173561-Binding Sites, pubmed-meshheading:2173561-Chemistry, Physical, pubmed-meshheading:2173561-Enzyme Stability, pubmed-meshheading:2173561-Hot Temperature, pubmed-meshheading:2173561-Kinetics, pubmed-meshheading:2173561-Molecular Sequence Data, pubmed-meshheading:2173561-Mutagenesis, Site-Directed, pubmed-meshheading:2173561-Oligodeoxyribonucleotides, pubmed-meshheading:2173561-Penicillanic Acid, pubmed-meshheading:2173561-Physicochemical Phenomena, pubmed-meshheading:2173561-Serine, pubmed-meshheading:2173561-Streptomyces, pubmed-meshheading:2173561-Structure-Activity Relationship, pubmed-meshheading:2173561-Thermodynamics, pubmed-meshheading:2173561-beta-Lactamases
pubmed:year
1990
pubmed:articleTitle
Role of the conserved amino acids of the 'SDN' loop (Ser130, Asp131 and Asn132) in a class A beta-lactamase studied by site-directed mutagenesis.
pubmed:affiliation
Laboratoire d'Enzymologie, Université de Liège, Belgium.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't